Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Suspended
Checked: June 1, 2026 at 8:35 PM UTC
| NCT Number | NCT06661915 |
| Recruiting Status | Suspended |
| Condition | Myeloproliferative Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 62 participants |
| Active Locations | 6 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | May 29, 2026 (3 days ago) |
As of June 1, 2026: Clinical trial NCT06661915 is currently suspended participants. This clinical trial study for myeloproliferative neoplasms is not currently accepting new participants at 6 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06661915 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06661915 was last updated 3 days ago (May 29, 2026). HelloStudys verifies this status automatically.